Interestingly, kynurenine was shown to promote several changes in BC cells, including the backward conversion of melatonin to N-acetylserotonin in the mitochondria, which promotes the activation of tyrosine receptor kinase β, ultimately increasing the survival and migration of BC cells [60]. The gene discussed is NTRK2; the disease is breast cancer.